Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
12
|
pubmed:dateCreated |
1977-2-16
|
pubmed:abstractText |
The abortifacient effectiveness of three intravaginal Silastic devices impregnated with 15(S)-15-methyl prostaglandin F2alpha (15(S)-Me-PGF2alpha) methyl ester in concentrations of 0.25%, 0.5%, and 1.0% was investigated. Each concentration was tested in 10 patients with gestations ranging from 8 to 19 weeks. Abortion was successfully induced by prostaglandin alone in 6 patients with the 0.25% device, in 9 patients with the 0.5% device, and all 10 patients treated with the 1.0% device. Additionally, three patients treated with the 0.25% device and one patient treated with the 0.5% device aborted with concomitant, continuous, intravenous oxytocin therapy. The mean abortion time with the 0.25% device was 16.43 hours; with the 0.5% device, 16.49 hours; and with the 1.0% device, 10.18 hours. The peripheral plasma levels of 15(S)-Me-PGF2alpha methyl ester were the most variable with the 0.5% device. The plasma levels of 15(S)-Me-PGF2alpha methyl ester of patients receiving the 0.25% device were similar to the levels of patients receiving the 1.0% device. The intravaginal Silastic device impregnated with 15(S)-Me-PGF2alpha methyl ester appears to be an effective abortifacient, but further study is indicated to determine the most efficient device with the fewest side effects.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Abortifacient Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Delayed-Action Preparations,
http://linkedlifedata.com/resource/pubmed/chemical/Prostaglandins, Synthetic,
http://linkedlifedata.com/resource/pubmed/chemical/Prostaglandins F,
http://linkedlifedata.com/resource/pubmed/chemical/Silicone Elastomers
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0015-0282
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
27
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1366-73
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1001521-Abortifacient Agents,
pubmed-meshheading:1001521-Abortion, Induced,
pubmed-meshheading:1001521-Adolescent,
pubmed-meshheading:1001521-Adult,
pubmed-meshheading:1001521-Delayed-Action Preparations,
pubmed-meshheading:1001521-Evaluation Studies as Topic,
pubmed-meshheading:1001521-Female,
pubmed-meshheading:1001521-Humans,
pubmed-meshheading:1001521-Pregnancy,
pubmed-meshheading:1001521-Pregnancy Trimester, First,
pubmed-meshheading:1001521-Prostaglandins, Synthetic,
pubmed-meshheading:1001521-Prostaglandins F,
pubmed-meshheading:1001521-Silicone Elastomers
|
pubmed:year |
1976
|
pubmed:articleTitle |
The abortifacient effectiveness and plasma prostaglandin concentrations with 15(S)-15-methyl prostaglandin F2alpha methyl ester-containing vaginal silastic devices.
|
pubmed:publicationType |
Journal Article
|